APA (7th ed.) Citation

Joshi, K., Dronova, M., Paterak, E., Nguyen, V. H., Kopel, H., Mansi, J., . . . Beck, E. (2025). Clinical Impact and Cost-Effectiveness of Updated 2023/24 COVID-19 mRNA Vaccination in High-Risk Populations in the United States. Infectious Diseases & Therapy, 14(6), 1219. https://doi.org/10.1007/s40121-025-01128-z

Chicago Style (17th ed.) Citation

Joshi, Keya, Mariia Dronova, Ewelina Paterak, Van H. Nguyen, Hagit Kopel, James Mansi, Nicolas Van de Velde, and Ekkehard Beck. "Clinical Impact and Cost-Effectiveness of Updated 2023/24 COVID-19 MRNA Vaccination in High-Risk Populations in the United States." Infectious Diseases & Therapy 14, no. 6 (2025): 1219. https://doi.org/10.1007/s40121-025-01128-z.

MLA (9th ed.) Citation

Joshi, Keya, et al. "Clinical Impact and Cost-Effectiveness of Updated 2023/24 COVID-19 MRNA Vaccination in High-Risk Populations in the United States." Infectious Diseases & Therapy, vol. 14, no. 6, 2025, p. 1219, https://doi.org/10.1007/s40121-025-01128-z.